Figure 1From: Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174 ANRS 12174 PROMISE-PEP trial design including scheduled follow-up visits. Back to article page